These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 220553)

  • 1. Receptor binding: a tool to aid in determining the role of peptides in behavior.
    Creese I
    Neurosci Res Program Bull; 1978 Dec; 16(4):498-509. PubMed ID: 220553
    [No Abstract]   [Full Text] [Related]  

  • 2. [Receptor-ligand reaction in the central nervous system (principal problems and prospects for development)].
    Korneev AIa; Mukhin AG
    Vestn Akad Med Nauk SSSR; 1981; (5):56-9. PubMed ID: 6269319
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of the novel antipsychotic drug amperozide and its metabolite FG5620 with central nervous system receptors and monoamine uptake sites: relation to behavioral and clinical effects.
    Svartengren J; Pettersson E; Björk A
    Biol Psychiatry; 1997 Aug; 42(4):247-59. PubMed ID: 9270901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.
    Hirst WD; Abrahamsen B; Blaney FE; Calver AR; Aloj L; Price GW; Medhurst AD
    Mol Pharmacol; 2003 Dec; 64(6):1295-308. PubMed ID: 14645659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship between iron metabolism in central nervous system and Parkinson's disease].
    Wang J; Jiang H; Xie JX
    Sheng Li Ke Xue Jin Zhan; 2003 Jan; 34(1):67-70. PubMed ID: 12778816
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurobiology of peptides.
    Iversen LL; Nicoll RA; Vale WW
    Neurosci Res Program Bull; 1978 Jun; 16(2):209-370. PubMed ID: 362233
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology of the central nervous system.
    Nelson SR; Walaszek EJ
    Prog Neurol Psychiatry; 1971; 26():123-49. PubMed ID: 4151158
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative analysis of binding parameters of [3H]N-methylscopolamine in central nervous system of muscarinic acetylcholine receptor knockout mice.
    Oki T; Takagi Y; Inagaki S; Taketo MM; Manabe T; Matsui M; Yamada S
    Brain Res Mol Brain Res; 2005 Jan; 133(1):6-11. PubMed ID: 15661360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrethroid-receptor interactions: stereospecific binding and effects on sodium channels in mouse brain preparations.
    Soderlund DM
    Neurotoxicology; 1985; 6(2):35-46. PubMed ID: 2410831
    [No Abstract]   [Full Text] [Related]  

  • 10. Are receptor studies useful for clinical practice?
    Richelson E
    J Clin Psychiatry; 1983 Sep; 44(9 Pt 2):4-9. PubMed ID: 6313632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic quantitation and anatomical mapping of 125I-galanin binding sites in the rat central nervous system.
    Melander T; Köhler C; Nilsson S; Hökfelt T; Brodin E; Theodorsson E; Bartfai T
    J Chem Neuroanat; 1988; 1(4):213-33. PubMed ID: 2477035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
    Moreland RB; Terranova MA; Chang R; Uchic ME; Matulenko MA; Surber BW; Stewart AO; Brioni JD
    Eur J Pharmacol; 2004 Aug; 497(2):147-54. PubMed ID: 15306199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide influences on the brain and behavior: introduction: perspectives on the behavioral effects of the neuropeptides.
    Sandman CA; Miller LH; Kastin AJ
    Adv Biochem Psychopharmacol; 1977; 17():1-9. PubMed ID: 920337
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prospects for using formed elements in the blood as an extracerebral model for the study of receptors in the central nervous system (review)].
    Zozulia AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):599-603. PubMed ID: 3012913
    [No Abstract]   [Full Text] [Related]  

  • 15. Progesterone derivatives that bind to the digitalis receptor: structure--activity relationships.
    Kim RS; LaBella FS; Zunza H; Zunza F; Templeton JF
    Mol Pharmacol; 1980 Nov; 18(3):402-5. PubMed ID: 7464804
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurosteroids and sigma1 receptors, biochemical and behavioral relevance.
    Maurice T
    Pharmacopsychiatry; 2004 Nov; 37 Suppl 3():S171-82. PubMed ID: 15547783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinase-activated receptor 2 (PAR(2)): development of a ligand-binding assay correlating with activation of PAR(2) by PAR(1)- and PAR(2)-derived peptide ligands.
    Al-Ani B; Saifeddine M; Kawabata A; Renaux B; Mokashi S; Hollenberg MD
    J Pharmacol Exp Ther; 1999 Aug; 290(2):753-60. PubMed ID: 10411588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Basic knowledge on receptor theory].
    Jin YC
    Sheng Li Ke Xue Jin Zhan; 1984 Jul; 15(3):268-76. PubMed ID: 6096968
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lyophilized membranes as a test system for analyzing the properties of neuromediator receptors and activity of neurotropic agents].
    Evdokimenko SG; Serebriakova OG; Zaĭtsev SV; Kurochkin IN; Zhukov VP
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1989; (5):24-9. PubMed ID: 2548629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-(2-Phenylcyclopropyl)imidazolines: reversed enantioselective interaction at I(1) and I(2) imidazoline receptors.
    Quaglia W; Bousquet P; Pigini M; Carotti A; Carrieri A; Dontenwill M; Gentili F; Giannella M; Maranca F; Piergentili A; Brasili L
    J Med Chem; 1999 Jul; 42(15):2737-40. PubMed ID: 10425083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.